Type 2 diabetes mellitus in children and adolescents

Pediatrics in Review

Volumn 34, Issue 12, 2013, Pages 541-548

  Dileepan, Kavitha ^a   Max Feldt, M ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; EXENDIN 4; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; MIGLITOL; ROSIGLITAZONE; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

ACANTHOSIS NIGRICANS; ARTICLE; BODY MASS; CHILDHOOD OBESITY; CLINICAL FEATURE; DIABETIC KETOACIDOSIS; DIABETIC PATIENT; DIARRHEA; DIETARY INTAKE; DISEASE CLASSIFICATION; DIZZINESS; DRUG MECHANISM; DYSPEPSIA; EYE EXAMINATION; FAMILY HISTORY; FLATULENCE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL INTOLERANCE; GASTROINTESTINAL TOXICITY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPERPHAGIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; INSULIN TREATMENT; LACTIC ACIDOSIS; LIFESTYLE MODIFICATION; LIVER FUNCTION TEST; MEDICATION COMPLIANCE; MICROALBUMINURIA; NAUSEA; NERVOUSNESS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; POLYDIPSIA; POLYURIA; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; REHABILITATION; RISK FACTOR; SECONDARY PREVENTION; SELF CARE; SIDE EFFECT; SLEEP DISORDERED BREATHING; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; ADOLESCENT; BLOOD; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; INCIDENCE; MASS SCREENING; PANCREAS ISLET BETA CELL; PEDIATRIC OBESITY; UNITED STATES;

ADOLESCENT; AUTOANTIBODIES; BODY MASS INDEX; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; GLUTAMATE DECARBOXYLASE; HUMANS; INCIDENCE; INSULIN-SECRETING CELLS; MASS SCREENING; PEDIATRIC OBESITY; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; RISK FACTORS; UNITED STATES;

EID: 84889864211     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.34-12-541     Document Type: Article

References (24)

1. Badaru A, Pihoker C. Type 2 diabetes in childhood: clinical characteristics and role of b-cell autoimmunity. Curr Diab Rep. 2012;12(1):75-81
2. Liese AD, D'Agostino RB Jr, Hamman RF, et al SEARCH for Diabetes in Youth Study Group. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics. 2006;118(4):1510-1518
3. Centers for Disease Control and Prevention. National diabetes fact sheet 2011: national estimates and general information on diabetes and prediabetes in the United States. Available at: http://www.cdc.gov/diabetes/pubs/factsheet11. htm. Accessed October 16,2012
4. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20(7):1183-1197
5. Dabelea D, Bell RA, D'Agostino RB Jr, et al Writing Group for the SEARCH for Diabetes in Youth Study Group. Incidence of diabetes in youth in the United States. JAMA. 2007;297(24):2716-2724
6. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23(3):381-389
7. Miller J, Silverstein JH, Rosenbloom AL. Type 2 diabetes in the child and adolescent. In: Lifshitz F, ed. Pediatric Endocrinology. Vol 1. Obesity, Diabetes Mellitus, Insulin Resistance, and Hypoglycemia. 5th ed. New York, NY: Informa Healthcare Inc; 2007:168-187
8. Pettitt DJ, Aleck KA, Baird HR, Carraher MJ, Bennett PH, Knowler WC. Congenital susceptibility to NIDDM: role of intrauterine environment. Diabetes. 1988;37(5):622-628
9. Pettitt DJ, Forman MR, Hanson RL, Knowler WC, Bennett PH. Breastfeeding and incidence of non-insulin-dependent diabetes mellitus in Pima Indians. Lancet. 1997;350(9072):166-168
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(1 Suppl 1):S64-S71
11. Chen L, Appel LJ, Loria C, et al. Reduction in consumption of sugar-sweetened beverages is associated with weight loss: the PREMIER trial. Am J Clin Nutr. 2009;89(5):1299-1306
12. Welsh JA, Sharma AJ, Grellinger L, Vos MB. Consumption of added sugars is decreasing in the United States. Am J Clin Nutr. 2011;94(3):726-734
13. Phipps K, Barker DJ, Hales CN, Fall CH, Osmond C, Clark PM. Fetal growth and impaired glucose tolerance in men and women. Diabetologia. 1993;36(3):225-228
14. Vignini A, Raffaelli F, Cester A, et al. Environmental and genetical aspects of the link between pregnancy, birth size, and type 2 diabetes. Curr Diabetes Rev. 2012;8(3):155-161
15. Kim G, Caprio S. Diabetes and insulin resistance in pediatric obesity. Pediatr Clin North Am. 2011;58(6):1355-1361, ix
16. Klingensmith GJ, Pyle L, Arslanian S, et al TODAY Study Group. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care. 2010;33(9):1970-1975
17. Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet. 2007;369(9575):1823-1831
18. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care. 2012;35(suppl 1):S11-S63
19. Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ; International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2006- 2007: type 2 diabetes mellitus in the child and adolescent. Pediatr Diabetes. 2008;9(5):512-526
20. Copeland KC, Silverstein J, Moore KR, et al American Academy of Pediatrics. Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents. Pediatrics. 2013;131(2):364-382
21. Zeitler P, Hirst K, Pyle L, et al TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366(24):2247-2256
22. Olansky L, Marchetti A, Lau H. Multicenter retrospective assessment of thiazolidinedione monotherapy and combination therapy in patients with type 2 diabetes: comparative subgroup analyses of glycemic control and blood lipid levels. Clin Ther. 2003; 25(suppl B):B64-B80.
23. Genuth S, Alberti KG, Bennett P, et al Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26(11):3160-3167
24. Adler AI. UKPDS-modelling of cardiovascular risk assessment and lifetime simulation of outcomes. Diab Med. 2008;25(suppl 2):41-46